Drug profile · INN
albutrepenonacog alfa
IDELVION
albutrepenonacog alfa (IDELVION) is a coagulation factor ix exogenous protein.
EMA: approved PMDA: approved Blood and blood forming organs (B02) B02BD04
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — albutrepenonacog alfa
- Class
- Blood and blood forming organs (B02)
- Route
- —
- Patents
- 0
- Programs
- 1
- Data quality
- 0.83
Quick answer
albutrepenonacog alfa (IDELVION) is a coagulation factor ix exogenous protein.
Key facts
INN albutrepenonacog alfa
Brand IDELVION
Mechanism Coagulation factor IX exogenous protein
Target Coagulation factor IX
Therapeutic class Blood and blood forming organs (B02)
ATC code B02BD04
Mechanism of action
Coagulation factor IX exogenous protein
Primary target: Coagulation factor IX
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
| PMDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is albutrepenonacog alfa?
albutrepenonacog alfa (IDELVION) is a coagulation factor ix exogenous protein.
What is the brand name for albutrepenonacog alfa?
IDELVION is a marketed brand name for albutrepenonacog alfa. Check FDA Drugs@FDA for the current US label holder and prescribing information.